rituximab-arrx Riabni
Selected indexed studies
- Rituximab. (, 2006) [PMID:30000857]
- Rituximab reference vs biosimilar utilization for oncology vs nononcology indications. (Am J Manag Care, 2023) [PMID:37948656]
- Uptake of rituximab biosimilars in Medicare and Medicaid in 2019-2022. (Am J Manag Care, 2024) [PMID:39745502]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Rituximab. (2006) pubmed
- Uptake of rituximab biosimilars in Medicare and Medicaid in 2019-2022. (2024) pubmed
- Rituximab reference vs biosimilar utilization for oncology vs nononcology indications. (2023) pubmed
- Occlusive Vasculitis Following Intravitreal Rituximab Injection for Primary Vitreoretinal Lymphoma. (2025) pubmed
- Physicochemical Stability of the Rituximab Biosimilar ABP 798 in Intravenous Bags Following Preparation and Storage. (2026) pubmed